U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07907055) titled 'PAUL(R) Glaucoma Implant Safety and Effectiveness Study' on Oct. 26.
Brief Summary: This prospective, multicenter clinical study is designed to evaluate the safety and effectiveness of the PAUL(R) Glaucoma Implant in adult patients with refractory glaucoma. Effectiveness will be assessed by measuring the reduction in intraocular pressure (IOP). Study results will support regulatory submissions to the U.S. Food and Drug Administration (FDA) and may also be used to support regulatory submissions and postmarketing surveillance activities in other countries.
Study Start Date: Nov. 01
Study Type: INTERVENTIONAL
Condition:
Refractory ...